Moreover, in vitro studies demonstrated that EphB2 inactivation promoted cell proliferation, motility, and invasion of bladder cancer, implying that EphB2 loss was involved in tumor metastasis and invasion of bladder cancer (Lee et al., 2021). Here, EPHB2 is linked to urinary bladder carcinoma.